Researchers identify key regulator of fetal growth in mice

May 18, 2017
Microscopy image of a normal mouse embryo (left) and one that is missing ZFP568 (right). Credit: Yang P., Macfarlan T., NICHD/NIH

A protein called ZFP568 regulates an important fetal growth hormone called insulin-like growth factor 2 (Igf2), according to a mouse study led by researchers at the National Institutes of Health. The study is one of the first to show that KRAB-zinc finger proteins, which are well-known for silencing viral genes left over from ancient infections, can also play an essential role in fetal and placental development.

Using a mouse model that lacked ZFP568, a KRAB-zinc finger , researchers at NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) found that ZFP568 suppresses a gene—Igf2—that is needed for balancing fetal and placental growth. The team discovered that ZFP568 prevented a placental version of Igf2 from being expressed too early, during a window of time soon after the embryo implants into the uterus. Precise expression of Igf2 is important because small changes in Igf2 levels can lead to under- and overgrowth conditions in people, such as Russell Silver syndrome and Beckwith-Wiedemann syndrome, respectively.

"ZFP568 is part of a large family of rapidly evolving proteins that play a role in recognizing and protecting the genome from ancient viruses that litter mammalian genomes," said Todd Macfarlan, Ph.D., the study's lead author and head of the Unit on Mammalian Epigenome Reprogramming at NICHD. "Our results underscore how KRAB-zinc finger proteins have evolved critical developmental functions, possibly as a byproduct of their primary role in genome defense."

In the study, fetal mice lacking ZFP568 failed to develop normally, suggesting that too much Igf2 is toxic in early development. The researchers also found that mammals, including humans, have ZPF568-like proteins, indicating that its Igf2 suppression may have played an important role in the early evolution of mammals. The study team is exploring whether ZFP568 has a similar function in humans and whether other KRAB-zinc finger proteins have evolved to aid in other essential, developmental processes.

The study is published in Science.

Explore further: IGF2 variant affects prenatal and postnatal growth

More information: "A placental growth factor is silenced in mouse embryos by the zinc finger protein ZFP568" science.sciencemag.org/cgi/doi … 1126/science.aah6895

Related Stories

IGF2 variant affects prenatal and postnatal growth

July 9, 2015
(HealthDay)—An IGF2 variant (c.191C—>A, p.Ser64Ter) affects postnatal as well as prenatal growth among those who have inherited the variant through paternal transmission, according to a report published online July 8 ...

New genetic link found between normal fetal growth and cancer

April 9, 2013
Two researchers at the National Institutes of Health discovered a new genetic link between the rapid growth of healthy fetuses and the uncontrolled cell division in cancer. The findings shed light on normal development and ...

Unhealthy diet during pregnancy could be linked to ADHD

August 18, 2016
New research led by scientists from King's College London and the University of Bristol has found that a high-fat, high-sugar diet during pregnancy may be linked to symptoms of ADHD in children who show conduct problems early ...

Recommended for you

New approach helps rodents with spinal cord injury breathe on their own

October 17, 2017
One of the most severe consequences of spinal cord injury in the neck is losing the ability to control the diaphragm and breathe on one's own. Now, investigators show for the first time in laboratory models that two different ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

New method to measure how drugs interact

October 17, 2017
Cancer, HIV and tuberculosis are among the many serious diseases that are frequently treated with combinations of three or more drugs, over months or even years. Developing the most effective therapies for such diseases requires ...

A new compound targets energy generation, thereby killing metastatic cells

October 17, 2017
Cancer can most often be successfully treated when confined to one organ. But a greater challenge lies in treating cancer that has metastasized, or spread, from the primary tumor throughout the patient's body. Although immunotherapy ...

Research finds that zinc binding is vital for regulating pH levels in the brain

October 17, 2017
Researchers in Oslo, Norway, have discovered that zinc binding plays an important role in the sensing and regulation of pH in the human brain. The findings come as one of the first studies that directly link zinc binding ...

Researchers find factor that delays wound healing

October 17, 2017
New research carried out at The University of Manchester has identified a bacterium—normally present on the skin that causes poor wound healing in certain conditions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.